Thyroid autoantibodies at baseline predict longer survival in non-small cell lung cancer patients treated with anti-programmed cell death-1 blockade: a prospective study.
Okuji T, Iwama S, Kobayashi T, Yasuda Y, Ito M, Yamagami A, Ando M, Hase T, Shibata H, Hatta T, Zhou X, Onoue T, Kawaguchi Y, Miyata T, Sugiyama M, Hagiwara D, Suga H, Banno R, Ando Y, Hashimoto N, Arima H.
Okuji T, et al. Among authors: zhou x.
Nagoya J Med Sci. 2024 Aug;86(3):452-463. doi: 10.18999/nagjms.86.3.452.
Nagoya J Med Sci. 2024.
PMID: 39355355
Free PMC article.